Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | Director | June 23, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,363 |
Reported balance
After 2026-06-23 transaction · row 1
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 7,697 · Balance 40,363 F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $37.78 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 10 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2026-05-11 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $34.50 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 9 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2025-05-07 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $43.91 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2024-05-08 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $30.72 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2023-05-09 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $26.10 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2022-05-11 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $19.98 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2021-05-06 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $16.80 | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · derivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 6,000 shares Expires 2020-05-07 F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 19,294 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,894 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · kind: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. F2 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 3,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,600 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:54 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 3,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018972 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 22:05 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 4,561 | $0.00 Strike: $9.74 | $0.00 |
DisclosureSEC source: 0001140361-18-017185 · doc1.xml · derivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,763 Underlying: Class A Common Stock · 4,561 shares Expires 2021-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 22:05 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 3,000 | $28.75 | $86,250.00 |
DisclosureSEC source: 0001140361-18-017185 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 22:05 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 1,561 | $28.45 | $44,410.45 |
DisclosureSEC source: 0001140361-18-017185 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,700 Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 22:05 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 4,561 | $9.74 | $44,424.14 |
DisclosureSEC source: 0001140361-18-017185 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 18:45 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 149 | $0.00 Strike: $9.74 | $0.00 |
DisclosureSEC source: 0001140361-18-016360 · doc1.xml · derivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,324 Underlying: Class A Common Stock · 149 shares Expires 2021-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 18:45 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 100 | $29.50 | $2,950.00 |
DisclosureSEC source: 0001140361-18-016360 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 18:45 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 49 | $29.25 | $1,433.25 |
DisclosureSEC source: 0001140361-18-016360 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800 Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 18:45 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 149 | $9.74 | $1,451.26 |
DisclosureSEC source: 0001140361-18-016360 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,527 | $0.00 Strike: $9.74 | $0.00 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · derivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,473 Underlying: Class A Common Stock · 2,527 shares Expires 2021-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,235 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · derivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,235 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 4,068 | $28.87 | $117,440.72 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $28.75 to $29.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 847 | $29.05 | $24,605.35 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,768 Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 2,527 | $9.74 | $24,612.98 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 847 | $29.05 | $24,605.35 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,088 Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:42 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 3,235 | $7.61 | $24,618.35 |
DisclosureSEC source: 0001140361-18-015952 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 135 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · derivative · entry 10 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,235 Underlying: Class A Common Stock · 135 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 100 | $29.15 | $2,915.00 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 35 | $28.95 | $1,013.25 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800 Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 135 | $7.61 | $1,027.35 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 6,660 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · derivative · entry 9 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,370 Underlying: Class A Common Stock · 6,660 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 8 | $28.70 | $229.60 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 4,883 | $28.65 | $139,897.95 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,708 Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 1,769 | $28.65 | $50,681.85 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,591 Read SEC document |
| March 26, 2018 Filed Mar 28, 2018 19:09 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 6,660 | $7.61 | $50,682.60 |
DisclosureSEC source: 0001140361-18-015433 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 347 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · derivative · entry 10 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,030 Underlying: Class A Common Stock · 347 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 216 | $29.50 | $6,372.00 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 40 | $31.00 | $1,240.00 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,916 Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 91 | $28.95 | $2,634.45 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,956 Read SEC document |
| March 23, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 347 | $7.61 | $2,640.67 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 132 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · derivative · entry 9 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,377 Underlying: Class A Common Stock · 132 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 100 | $31.20 | $3,120.00 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 32 | $30.80 | $985.60 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,800 Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 22:38 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 132 | $7.61 | $1,004.52 |
DisclosureSEC source: 0001140361-18-015049 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2018 Filed Mar 22, 2018 20:57 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 5,000 | $31.10 | $155,500.00 |
DisclosureSEC source: 0001140361-18-014677 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:57 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 7,433 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-014677 · doc1.xml · derivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,509 Underlying: Class A Common Stock · 7,433 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:57 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 612 | $31.40 | $19,216.80 |
DisclosureSEC source: 0001140361-18-014677 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,700 Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:57 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingClass A Common Stock | 1,821 | $31.05 | $56,542.05 |
DisclosureSEC source: 0001140361-18-014677 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,312 Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:57 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionClass A Common Stock | 7,433 | $7.61 | $56,565.13 |
DisclosureSEC source: 0001140361-18-014677 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 22:10 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,142 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001140361-18-014341 · doc1.xml · derivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,942 Underlying: Class A Common Stock · 3,142 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 22:10 UTC | NRC HEALTH NRCIA/B · Entity 5534 | SaleClass A Common Stock | 2,383 | $31.74 | $75,642.14 |
DisclosureSEC source: 0001140361-18-014341 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $31.50 to $32.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.